Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

UCB’s Vimpat NDA Seeks Indications For Epileptic Seizures, Diabetic Pain

Related Content

Generic Keppra Set For Launch In November 2008 After UCB Settles

Oct 05 2007

UCB’s Cimzia Rejected For Crohn’s By EMEA Committee

Nov 16 2007

May The Schwarz Be With You: UCB Proposes $5.6 Bil. Acquisition

Sep 25 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window